Stratos Wealth Advisors LLC Sells 109 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Stratos Wealth Advisors LLC lessened its position in iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,893 shares of the financial services provider’s stock after selling 109 shares during the period. Stratos Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $515,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the company. SPC Financial Inc. raised its stake in shares of iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after acquiring an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management increased its stake in shares of iShares Biotechnology ETF by 2.7% in the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after buying an additional 76 shares during the period. Chicago Partners Investment Group LLC raised its holdings in iShares Biotechnology ETF by 2.5% during the 4th quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock worth $510,000 after purchasing an additional 94 shares during the last quarter. Capital Investment Advisors LLC raised its position in shares of iShares Biotechnology ETF by 1.0% during the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after acquiring an additional 99 shares during the last quarter. Finally, Magnus Financial Group LLC grew its position in shares of iShares Biotechnology ETF by 0.8% during the 4th quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock worth $1,714,000 after buying an additional 104 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $137.67 on Friday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm has a fifty day moving average of $136.22 and a 200-day moving average of $141.41.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.